3191 - Urethral Dose as a Predictor of Genitourinary Toxicity and Patient-Reported Quality of Life after Prostate Stereotactic Body Radiotherapy with Focal Intraprostatic Boost: Secondary Analysis of a Phase

12:45pm - 02:00pm PT

Hall F

Presenter(s)

Mustafa Basree, DO, MS - University of Wisconsin Hospitals and Clinics, Madison, WI